Corteva releases first quarter 2025 results

Corteva ended the first quarter of 2025 with net income of US$667 million, up 77% compared to the same period in 2024. Net revenue totaled US$4,42 billion, down 2%. However, organic sales increased 3%, driven by technology and biologicals.

The positive performance allowed the company to reaffirm its targets for the year. Revenue projections remain between US$17,2 billion and US$17,6 billion. Adjusted earnings per share are expected to reach US$2,70 to US$2,95, representing double-digit growth. Corteva also intends to repurchase US$1 billion in shares.

In the seeds division, revenue fell 2% to US$2,71 billion. Volume grew 2% in North America, but fell in Latin America, where corn planted area shrank in Argentina. The appreciation of the dollar negatively impacted results in several regions.

In crop protection, sales fell 2%, but demand for new products and biologicals led to a 5% increase in volume. The division's operating margin rose 425 basis points, supported by cost cuts and productivity gains.

According to CEO Chuck Magro, the focus on operational discipline ensured margin gains and cost reduction. He highlighted the strength of the technology portfolio and the company's preparation for a still uncertain market environment.